Literature DB >> 33107706

The role of surgery on the primary tumor site in bladder cancer with distant metastasis: significance of histology type and metastatic pattern.

Ping Wang1, Shuang Zang2, Guangqi Li1, Weiling Qu1, Shuyao Li1, Qiao Qiao1, Yuanjun Jiang3.   

Abstract

Due to the limited data and research on bladder cancer with distant metastasis, the role of surgery on the primary tumor site in metastatic bladder cancer has been controversial. The aim of this study was to investigate the impact of surgery on patients with metastatic bladder cancer and to identify any factors correlated with the treatment efficacy. Using the Surveillance, Epidemiology and End Results dataset, we performed a large population-based retrospective study. We classified patents with distant metastasis into subgroups according to their histology type and metastatic pattern. Propensity score matching (PSM) was used to balance clinical variables bias in a 1:3 ratio. A total of 2470 patients with distant metastasis were identified from 2010 to 2016. After PSM, the study eventually included 1068 patients in the surgery group and 356 patients in the non-surgery group. The histologic types, the number of metastatic sites, liver metastasis, surgery, and chemotherapy were significant prognostic variables for patients with distant metastasis before and after PSM. In terms of histologic types, the survival of patients with transitional cell papillary carcinoma, transitional cell non-papillary carcinoma and adenocarcinoma can be improved by surgery alone, while the survival of patients with squamous cell carcinoma can be improved only by combining chemotherapy and surgery. In terms of the number of metastatic sites, surgery alone was an independent prognostic factor in patients with 1 or 2 metastatic sites. In terms of the specificity of metastatic organs, surgery affected overall survival for patients with bone metastasis only, liver metastasis only and lung metastasis only, but for distant lymph nodes metastasis only. It may be helpful to classify patients with bladder cancer and distant metastasis into different groups by integrating variables including histology types and metastatic patterns to choose appropriate treatment strategies.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  PSM; SEER; bladder cancer; distant metastasis; surgery

Mesh:

Year:  2020        PMID: 33107706      PMCID: PMC7774714          DOI: 10.1002/cam4.3560

Source DB:  PubMed          Journal:  Cancer Med        ISSN: 2045-7634            Impact factor:   4.452


  23 in total

1.  Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

Authors:  C N Sternberg; A Yagoda; H I Scher; R C Watson; N Geller; H W Herr; M J Morse; P C Sogani; E D Vaughan; N Bander
Journal:  Cancer       Date:  1989-12-15       Impact factor: 6.860

2.  Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.

Authors:  Joaquim Bellmunt; Hans von der Maase; Graham M Mead; Iwona Skoneczna; Maria De Santis; Gedske Daugaard; Andreas Boehle; Christine Chevreau; Luis Paz-Ares; Leslie R Laufman; Eric Winquist; Derek Raghavan; Sandrine Marreaud; Sandra Collette; Richard Sylvester; Ronald de Wit
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

3.  Age-stratified distribution of metastatic sites in bladder cancer: A population-based analysis.

Authors:  Marco Bianchi; Florian Roghmann; Andreas Becker; Shyam Sukumar; Alberto Briganti; Mani Menon; Pierre I Karakiewicz; Maxine Sun; Joachim Noldus; Quoc-Dien Trinh
Journal:  Can Urol Assoc J       Date:  2014 Mar-Apr       Impact factor: 1.862

4.  Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary Database.

Authors:  Marco Moschini; Evanguelos Xylinas; Stefania Zamboni; Agostino Mattei; Günter Niegisch; Evan Y Yu; Aristotelis Bamias; Neeraj Agarwal; Srikala S Sridhar; Cora N Sternberg; Ulka N Vaishampayan; Jonathan E Rosenberg; Joaquim Bellmunt; Matthew D Galsky; Francesco Montorsi; Andrea Necchi
Journal:  Eur Urol Oncol       Date:  2019-07-13

Review 5.  [Surgical treatment of metastatic urothelial carcinoma of the bladder: Review of the Cancer Committee of the French Association of Urology].

Authors:  Y Neuzillet; S Larré; E Comperat; M Rouprêt; G Pignot; N Houede; H Quintens; H Wallerand; C Roy; M Soulie; C Pfister
Journal:  Prog Urol       Date:  2013-04-17       Impact factor: 0.915

6.  A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.

Authors:  Jeremy W Martin; Francis A Jefferson; Melissa Huang; John M Sung; Jenny Chang; Keyhan Piranviseh; Argyrios Ziogas; Hoda Anton-Culver; Ramy F Youssef
Journal:  Clin Genitourin Cancer       Date:  2020-01-16       Impact factor: 2.872

7.  Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Authors:  Arnaud Méjean; Alain Ravaud; Simon Thezenas; Sandra Colas; Jean-Baptiste Beauval; Karim Bensalah; Lionnel Geoffrois; Antoine Thiery-Vuillemin; Luc Cormier; Hervé Lang; Laurent Guy; Gwenaelle Gravis; Frederic Rolland; Claude Linassier; Eric Lechevallier; Christian Beisland; Michael Aitchison; Stephane Oudard; Jean-Jacques Patard; Christine Theodore; Christine Chevreau; Brigitte Laguerre; Jacques Hubert; Marine Gross-Goupil; Jean-Christophe Bernhard; Laurence Albiges; Marc-Olivier Timsit; Thierry Lebret; Bernard Escudier
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

8.  Survival Benefits Based on the Number of Lymph Nodes Removed during Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis.

Authors:  Min Soo Choo; Sangjun Yoo; Hyeong Dong Yuk; Chang Wook Jeong; Min Chul Cho; Cheol Kwak; Hyeon Jeong; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  J Clin Med       Date:  2020-06-21       Impact factor: 4.241

9.  Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival.

Authors:  Joanne Watt; Daniel G Maguire; Cherith N Reid; John V Lamont; Stephen P Fitzgerald; Mark W Ruddock
Journal:  Res Rep Urol       Date:  2020-04-28

10.  Clear Cell Adenocarcinoma of the Urinary Bladder Is a Glycogen-Rich Tumor with Poorer Prognosis.

Authors:  Zhengqiu Zhou; Connor J Kinslow; Peng Wang; Bin Huang; Simon K Cheng; Israel Deutsch; Matthew S Gentry; Ramon C Sun
Journal:  J Clin Med       Date:  2020-01-03       Impact factor: 4.241

View more
  2 in total

1.  The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma.

Authors:  Xiaodi Zhang; Ping Wang; Kaiyan Qi; Qiao Qiao; Yuanjun Jiang
Journal:  Cancer Med       Date:  2021-10-14       Impact factor: 4.452

2.  A Model for Identifying Optimal Patients for Primary Tumor Resection in Patients With Metastatic Bladder Cancer.

Authors:  Jintao Hu; Zhenming Zheng; Junjiong Zheng; Weibin Xie; Huabin Su; Jingtian Yang; Zixin Xu; Zefeng Shen; Hao Yu; Xinxiang Fan; Jianqiu Kong; Jinli Han
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.